Concepedia

Publication | Open Access

Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia

DOIFull Paper Access

78

Citations

30

References

2021

Year

Eben I. Lichtman, Hongwei Du, Peishun Shou, Feifei Song, Kyogo Suzuki, Sarah Ahn, Guangming Li, Soldano Ferrone, Lishan Su, Barbara Savoldo,
Clinical Cancer Research

Abstract

B7-H3 is a promising target for AML-directed CAR-T therapy. B7-H3.CAR-Ts control AML and have a favorable safety profile in preclinical models.

References

YearCitations

Page 1